PORT WASHINGTON, N.Y., May 22, 2025 /PRNewswire/ -- EQUASHIELD®, a global leader in Closed System Transfer Devices (CSTDs) and automated compounding solutions, proudly announces that it has been ...
PORT WASHINGTON, N.Y., Sept. 8, 2023 /PRNewswire/ -- EQUASHIELD, a pioneer in closed system transfer devices (CSTDs) and automated pharmacy compounding solutions, is thrilled to announce its ...
PORT WASHINGTON, New York, Dec. 4, 2019 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, has marked its 10-year milestone ...
New PP&P State of Pharmacy Compounding report shows EQUASHIELD® now accounts for 44% of CSTDs in use for hazardous drug preparation PORT WASHINGTON, N.Y., May 8, 2026 /PRNewswire/ -- In a healthcare ...
DUBLIN, May 5, 2021 /PRNewswire/ -- The "Closed System Drug Transfer Device Market Share, Size, Trends, Industry Analysis Report, By Type; By Component; By Closing Mechanism; By Technology; By End-Use ...
The deal puts Equashield at a valuation of $300 million Equashield was founded in 2009 Since inception in 1989, Nordic Capital has invested more than 20 billion euros in equity capital in over 125 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results